Astrocyte Glutamine Synthetase: Importance in Hyperammonemic Syndromes and Potential Target for Therapy

Neurotherapeutics

Volumn 7, Issue 4, 2010, Pages 452-470

  Brusilow, Saul W ^a   Koehler, Raymond C ^a   Traystman, Richard J ^b   Cooper, Arthur J L ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Astrocyte swelling; Cerebral edema; Glutamine synthetase; Hepatic encephalopathy; Hyperammonemia

Indexed keywords

AMMONIA; GLUTAMATE AMMONIA LIGASE; METHIONINE SULFOXIMINE;

AMINO ACID SYNTHESIS; AMMONIA BLOOD LEVEL; ARTICLE; ASTROCYTE; BRAIN EDEMA; BRAIN METABOLISM; ENZYME INHIBITION; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERAMMONEMIA; LIVER FUNCTION; NEUROTOXICITY; NITROGEN METABOLISM; PRIORITY JOURNAL; PROTEIN TARGETING;

ANIMALS; ASTROCYTES; ENZYME INHIBITORS; GLUTAMATE-AMMONIA LIGASE; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERAMMONEMIA;

EID: 77957073688     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2010.05.015     Document Type: Article

References (197)

1. van Caulaert C., Deviller C. Ammoniémie expérimentale après ingestion de chlorure d'ammonium chez l'homme à l'état normal et pathologique. Compt Rend Soc Biol (Paris) 1932, 111:50-52.
2. van Caulaert C., Deviller C., Halff M. Troubles provoqués par l'ingestion de sels ammoniacaux chez l'homme atteint de cirrhose de Laënnec. Compt Rend Soc Biol (Paris) 1932, 111:739-740.
3. Kirk E. Amino acid metabolism in liver disease. Acta Med Scand Suppl 1936, 77:1-147.
4. Mullen K.D. Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Aliment Pharmacol Ther 2007, 25(suppl 1):11-16.
5. Gabuzda G.J., Phillips G.B., Davidson C.S. Reversible toxic manifestations in patients with cirrhosis of the liver given cation-exchange resins. New Engl J Med 1952, 246:124-130.
6. Phillips G.B., Schwartz B.R., Gabuzda G.J., Davidson C.S. The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances. N Engl J Med 1952, 247:239-246.
7. Shih V. Hereditary urea cycle disorders. The urea cycle 1976, 369-370. John Wiley & Sons, New York. S. Grisolía, R. Baguena, F. Mayor (Eds.).
8. Mitchell R.B., Wagner J.E., Karp J.E., et al. Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med 1988, 85:662-667.
9. Nott L., Price T.J., Pittman K., Patterson K., Fletcher J. Hyperammonemia encephalopathy: An important cause of neurological deterioration following chemotherapy. Leuk Lymphoma 2007, 48:1702-1711.
10. Samtoy B., DeBeukelaer M.M. Ammonia encephalopathy secondary to urinary tract infection with Proteus mirabilis. Pediatrics 1980, 65:294-297.
11. Sato S., Yokota C., Toyoda K., Naganuma M., Minematsu K. Hyperammonemic encephalopathy caused by urinary tract infection with urinary retention. Eur J Int Med 2008, 19:e78-e79.
12. Vossler D.G., Wilensky A.J., Cawthon D.F., et al. Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy. Epilepsia 2002, 43:154-159.
13. Segura-Bruna N., Rodriguez-Campello A., Puente V., Roquer J. Valproate-induced hyperammonemic encephalopathy. Acta Neurol Scand 2006, 114:1-7.
14. Lamiell J.J., Ducey J.P., Freese-Kepczyk B.J., Musio F., Hansberry K.L. Essential amino acid-induced adult hyperammonemic encephalopathy and hypophosphatemia. Crit Care Med 1990, 18:451-452.
15. Alonso E.M., Squires R.H., Whitington P.F. Acute liver failure in children. Liver disease in children 2008, 71-96. Lippincott, Philadelphia. 3rd edit. F.J. Suchy, R.J. Sokol, W.F. Balistreri (Eds.).
16. Lee W.M. Acute liver failure. N Engl J Med 1993, 329:1862-1872.
17. Diseases of the liver and biliary system 1996, 94-95. Blackwell Science, London. S. Sherlock, J. Dooley (Eds.).
18. Ferenci P., Herneth A., Steindl P. Newer approaches to therapy of hepatic encephalopathy. Semin Liver Dis 1996, 16:329-338.
19. Bessman S.P. Ammonia metabolism in animals. Inorganic nitrogen metabolism 1956, 408-436. The Johns Hopkins Press, Baltimore, MD. W.D. McElroy, B. Glass (Eds.).
20. Bessman S.P. Blood ammonia. Adv Clin Chem 1959, 2:135-180.
21. Adams R.D., Foley J.M. The neurological disorder associated with liver disease. Res Publ Assoc Res Nerv Ment Dis Proc 1953, 32:198-237.
22. McDermott W.V., Adams R.D. Episodic stupor associated with an Eck fistula in the human with particular reference to the metabolism of ammonia. J Clin Invest 1954, 33:1-9.
23. Fraser C.L., Arieff A.I. Hepatic encephalopathy. N Engl J Med 1985, 313:865-873.
24. Cooper A.J.L., Plum F. Biochemistry and physiology of brain ammonia. Physiol Rev 1987, 67:440-519.
25. Lockwood A.H. Ammonia-induced encephalopathy. Cerebral energy metabolism and metabolic encephalopathy 1985, 203-227. Plenum Press, New York. D.W. McCandless (Ed.).
26. Cirrhosis, hepatic encephalopathy, and ammonium toxicity. advances in experimental medicine and biology 1990, vol 272. Plenum Press, New York. S. Grisolía, V. Felipo, M.-D. Miñana (Eds.).
27. Progress in hepatic encephalopathy and metabolic nitrogen exchange 1991, CRC Press, Boca Raton, FL. F. Bengtsson, Jeppsson, T. Almdal, H. Vilstrup (Eds.).
28. Hepatic encephalopathy 1994, 43-61. Medi-Ed Press, Bloomington, IL. H.O. Conn, J. Bircher (Eds.).
29. Advances in hepatic encephalopathy and metabolic nitrogen exchange 1995, CRC Press, Boca Raton, FL. L. Capocaccia, M. Merli, O. Riggio (Eds.).
30. Felipo V., Butterworth R.F. Neurobiology of ammonia. Prog Neurobiol 2002, 67:259-279.
31. Felipo V., Butterworth R.F. Mitochondrial dysfunction in acute hyperammonemia. Neurochem Int 2002, 40:487-491.
32. Lockwood A.H. Blood ammonia levels and hepatic encephalopathy. Metab Brain Dis 2004, 19:345-349.
33. Brusilow S.W. Determination of urine orotate and orotidine and plasma ammonium. Techniques in diagnostic human biochemical genetics: a laboratory manual 1991, 345-357. Wiley-Liss, New York. F.A. Hommes (Ed.).
34. Batshaw M.L., Brusilow S., Waber L., et al. Treatment of inborn errors of urea synthesis. N Engl J Med 1982, 306:1387-1392.
35. Msall M., Batshaw L., Suss R., Brusilow S.W., Mellits E.D. Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea cycle enzymopathies. N Engl J Med 1984, 310:1500-1505.
36. Butterworth R.F., Giguère J.F., Michaud J., Lavoie J., Layrargues G.P. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987, 6:1-12.
37. Brusilow S.W., Maestri N.E. Urea cycle disorders: Diagnosis, pathophysiology, and therapy. Adv Pediatr 1996, 43:127-170.
38. Butterworth R.F. Complications of cirrhosis. III hepatic encephalopathy. J Hepatol 2000, 32:171-180.
39. Häussinger D., Kircheis G., Fischer R., Schleiess F., vom Dahl S. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low grade cerebral edema?. J Hepatol 2000, 32:1035-1038.
40. Weissenborn K., Ennen J.C., Schomerus H., Rückert N., Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001, 34:768-773.
41. Brusilow S.W. Hyperammonemic encephalopathy. Medicine 2002, 81:240-249.
42. Albrecht J., Jones E.A. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J Neurol Sci 1999, 30:138-146.
43. Jalan R., Shawcross D., Davis D. The molecular pathogenesis of hepatic encephalopathy. Int J Biochem Cell Biol 2003, 35:1175-1181.
44. Blei A.T. Brain edema in acute liver failure. Crit Care Clin 2008, 24:99-114.
45. Zwingmann C., Butterworth R. An update on brain glutamine synthesis and its relation to cell-specific energy metabolism in the hyperammonemic brain: Further studies using NMR spectroscopy. Neurochem Int 2005, 47:19-30.
46. Maestri N.E., Clissold D., Brusilow S.W. Neonatal onset ornithine transcarbamylase deficiency: A retrospective analysis. J Pediatr 1999, 134:268-272.
47. Lavoie J., Giguère J.F., Layrargues G.P., Butterworth R.F. Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. J Neurochem 1987, 49:692-697.
48. Connelly A., Cross J.H., Gadian D.G., Hunter J.V., Kirkham F.J., Leonard J.V. Magnetic resonance spectroscopy shows increased glutamine in ornithine carbamoyl transferase deficiency. Pediatr Res 1993, 33:77-81.
49. 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy. Hepatogastroenterology 2003, 50:2149-2153.
50. Wong Y.C., Au W.L., Xu M., Ye J., Lim C.C. Magnetic resonance spectroscopy in adult-onset citrullinemia: elevated glutamine levels in comatose patients. Arch Neurol 2007, 64:1034-1037.
51. Ross B.D., Jacobson S., Villamil F., et al. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994, 193:457-463.
52. 1H magnetic resonance in the study of hepatic encephalopathy in humans. Metab Brain Dis 2002, 17:415-429.
53. Shawcross D.L., Balata S., Olde Damink S.W.M., et al. Low myoinositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia. Am J Physiol Gastrointest Liver Physiol 2004, 287:G503-G509.
54. Kojic J., Robertson P.L., Quint D.J., Martin D.M., Pang Y., Sundgren P.C. Brain glutamine by MRS in a patient with urea cycle disorder and coma. Pediatr Neurol 2005, 32:143-146.
55. Swain M.S., Blei A.T., Butterworth R.F., Kraig R.P. Intracellular pH rises and astrocytes swell after portacaval anastomosis in rats. Am J Physiol 1991, 261:R1491-R1496.
56. 15N heteronuclear multiple-quantum coherence-transfer NMR in severely hyperammonemic rat. J Neurochem 1997, 68:1209-1220.
57. 13N-labeled ammonia in rat brain. J Biol Chem 1979, 254:4982-4992.
58. 13N-ammonia from blood to brain. A new regional residue detection model. Circ Res 1981, 48:913-937.
59. Lockwood A.H., Yap E.W., Wong W.H. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 1991, 11:337-341.
60. Weigle C.G., Koehler R.C., Brusilow S.W., Traystman R.J. Arterial pH modulation of regional cerebral blood flow during hyperammonemia in dogs. Am J Physiol Heart Circ Physiol 1990, 259:H34-H41.
61. 13N-ammonia PET. Metab Brain Dis 2007, 22:277-284.
62. Ahl B., Weissenborn K., van den Hoff J., et al. Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 2004, 40:73-79.
63. Gibson G.E., Zimber A., Krook L., Richardson E.P., Visek W.J. Brain histology and behavior of mice injected with urease. J Neuropath Exp Neurol 1974, 33:201-221.
64. Hindfelt B., Plum F., Duffy T.E. Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts. J Clin Invest 1977, 59:386-396.
65. Gjedde A., Lockwood A.H., Duffy T.E., Plum F. Cerebral blood flow and metabolism in chronically hyperammonemic rats: effect of an acute ammonia challenge. Ann Neurol 1978, 3:325-330.
66. Giguère J.F., Butterworth R.F. Amino acid changes in regions of the CNS in relation to function in experimental portal-systemic encephalopathy. Neurochem Res 1984, 9:1309-1321.
67. Hawkins R.A., Jessy J. Hyperammonaemia does not impair brain function in the absence of glutamine synthesis. Biochem J 1991, 277:697-703.
68. Pasantes-Morales H., Franco R. Astrocyte cellular swelling: Mechanisms and relevance to brain edema. The Role of Glia in Neurotoxicity 2004, 173-190. CRC Press, Boca Raton, FL. 2nd Edit. M. Aschner, L.G. Costa (Eds.).
69. 13N-ammonia in rat striatum using microdialysis with radio-LC method. J Neurosci Methods 2009, 184:37-41.
70. Cooper A.J.L., Mora S.N., Cruz N.F., Gelbard A.S. Cerebral ammonia metabolism in hyperammonemic rats. J Neurochem 1985, 44:1716-1723.
71. Bessman S.P., Bessman A.N. The cerebral and peripheral uptake of ammonia in liver disease with an hypothesis for the mechanism of hepatic coma. J Clin Invest 1955, 34:622-628.
72. Shorey J., McCandless D.W., Schenker S. Cerebral α-ketoglutarate in ammonia intoxication. Gastroenterology 1967, 53:706-711.
73. Cooper A.J.L., Vergara F., Duffy T.E. Cerebral glutamine synthetase. Glutamine, glutamate and GABA in the central nervous system 1983, 77-93. Alan R. Liss, New York. L. Hertz, E. Kvamme, E.G. McGeer, A. Schousboe (Eds.).
74. 31P nuclear magnetic resonance. J Neurochem 1989, 52:741-749.
75. Hirata T., Koehler R.C., Brusilow S.W., Traystman R.J. Preservation of cerebral blood flow responses to hypoxia and arterial pressure alterations in hyperammonemic rats. J Cereb Blood Flow Metab 1995, 15:835-844.
76. Oldendorf W.H., Szabo J. Amino acid assignment to one of three blood-brain barrier amino acid carriers. Am J Physiol 1976, 230:94-98.
77. Berl S., Takagaki G., Clarke D.D., Waelsch H. Carbon dioxide fixation in the brain. J Biol Chem 1962, 237:2570-2573.
78. Zwingmann C. The anaplerotic flux and ammonia detoxification in hepatic encephalopathy. Metab Brain Dis 2007, 22:235-249.
79. Johansen M.L., Bak L.K., Schousboe A., et al. The metabolic role of isoleucine in detoxification of ammonia in cultured mouse neurons and astrocytes. Neurochem Int 2007, 50:1042-1051.
80. Howse D.C., Duffy T.E. Control of the redox state of the pyridine nucleotides in the rat cerebral cortex. Effect of electroshock-induced seizures. J Neurochem 1975, 24:935-940.
81. García-Espinosa M.A., Wallin R., Hutson S.M., Sweatt A.J. Widespread neuronal expression of branched-chain aminotransferase in the CNS: implications for leucine/glutamate metabolism and for signaling by amino acids. J Neurochem 2007, 100:1458-1468.
82. Hawkins R.A., Jessy J., Mans A.M., DeJoseph M.R. Effects of reducing brain glutamine synthesis on metabolic symptoms of hepatic encephalopathy. J Neurochem 1993, 60:1000-1006.
83. 15N NMR. J Neurochem 1998, 70:1304-1315.
84. 15N-NMR spectroscopy studies of ammonia transport and glutamine synthesis in the hyperammonemic rat brain. Dev Neurosci 1998, 20:434-443.
85. 13C]glucose infusion. J Neurochem 2001, 76:975-989.
86. McKhann G.M., Tower D.B. Ammonia toxicity and cerebral oxidative metabolism. Am J Physiol 1961, 200:420-424.
87. Lai J.C.K., Cooper A.J.L. Brain α-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution and effects of inhibitors. J Neurochem 1986, 47:1376-1386.
88. Lowry O.H., Passonneau J.V. Kinetic evidence for multiple binding sites on phosphofructokinase. J Biol Chem 1966, 241:2268-2279.
89. Fitzpatrick S.M., Cooper A.J.L., Duffy T.E. Use of β-methylene-DL-aspartate to assess the role of aspartate aminotransferase in cerebral oxidative metabolism. J Neurochem 1983, 41:1370-1383.
90. Bjerring P.N., Hauerberg J., Frederiksen H.J., et al. Cerebral glutamine concentration and lactate-pyruvate ratio in patients with acute liver failure. Neurocrit Care 2008, 9:3-7.
91. Barbiroli B., Gaiani S., Lodi R., et al. Abnormal brain energy metabolism shown by in vivo phosphorus magnetic resonance spectroscopy in patients with chronic liver disease. Brain Res Bull 2002, 59:75-82.
92. Weissenborn K., Bokemeyer M., Ahl B., et al. Functional imaging of the brain in patients with liver cirrhosis. Metab Brain Dis 2004, 19:269-280.
93. Cavanagh J.B., Kyu M.H. Type II Alzheimer change experimentally produced in astrocytes in the rat. J Neurol Sci 1971, 12:63-75.
94. Cole M., Rutherford R.B., Smith F.O. Experimental ammonia encephalopathy in the primate. Arch Neurol 1972, 26:130-136.
95. Zamora A.J., Cavanagh J.B., Kyu M.H. Ultrastructural responses of the astrocytes to portacaval anastomosis in the rat. J Neurol Sci 1973, 18:25-45.
96. Norenberg M.D., Lapham L.W. The astrocyte response in experimental portal systemic encephalopathy. An electron microscopic study. J Neuropath Exp Neurol 1974, 33:422-435.
97. Norenberg M.D. A light and electron microscopic study of experimental portal-systemic (ammonia) encephalopathy. Progression and reversal of the disorder. Lab Invest 1977, 36:618-627.
98. Voorhies T.M., Ehrlich M.E., Duffy T.E., Petito C.K., Plum F. Acute hyperammonemia in the young primate: physiologic and neuropathologic correlates. Pediatr Res 1983, 17:970-975.
99. Traber P.G., Dal Canto M., Ganger D.R., Blei A.T. Electron microscopic evaluation of brain edema in rabbits with galactosamine-induced hepatic failure: ultrastructure and integrity of the blood-brain barrier. Hepatology 1987, 7:1272-1277.
100. Norenberg M.D. Astrocyte responses to CNS injury. J Neuropath Exp Neurol 1994, 53:213-220.
101. Willard-Mack C.L., Koehler R.C., Hirata T., et al. Inhibition of glutamine synthetase reduces ammonia-induced astrocyte swelling in rat. Neuroscience 1996, 71:589-599.
102. Martinez A. Electron microscopy in human hepatic encephalopathy. Acta Neuropath 1968, 11:82-86.
103. Partin J.S., McAdams A.J., Partin J.C., Schubert W.K., McLaurin R.L. Brain ultrastructure in Reye's disease - II. Acute injury and recovery process in three children. J Neuropathol Exp Neurol 1978, 37:796-819.
104. Bruton C.J., Corsellis J.A.N., Russell A. Hereditary hyperammonaemia. Brain 1970, 93:423-434.
105. Gregorios J.B., Mozes L.W., Norenberg L.-O.B., Norenberg M.D. Morphologic effects of ammonia on primary astrocyte cultures: II. Electron microscopic studies. J Neuropath Exp Neurol 1985, 44:404-414.
106. Martinez-Hernandez A., Bell K.P., Norenberg M.D. Glutamine synthetase: glial localization in brain. Science 1977, 195:1356-1358.
107. Norenberg M.D., Martinez-Hernandez A. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 1979, 161:303-310.
108. 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography. Hepatology 2006, 43:42-50.
109. 13N-ammonia PET. Metab Brain Dis 2007, 22:277-284.
110. Sørensen M., Munk O.L., Keiding S. Backflux of ammonia from brain to blood in human subjects with and without hepatic encephalopathy. Metab Brain Dis 2009, 24:237-242.
111. 13N-ammonia metabolites in blood. Metab Brain Dis 2010, 25:49-56.
112. De Graaf A.A., Deutz N.E.P., Bosman D.K., Chamuleau R.A., de Haan J.G., Bovee W.M. The use of in vivo proton NMR to study the effects of hyperammonemia in the rat cerebral cortex. NMR Biomed Med 1991, 4:31-37.
113. 13C-magnetic resonance spectroscopy. Dev Neurosci 1998, 20:427-433.
114. Zwingmann C. Nuclear magnetic resonance studies of energy metabolism and glutamine shunt in hepatic encephalopathy and hyperammonemia. J Neurosci Res 2007, 85:3429-3442.
115. Vergara F., Duffy T.E., Plum F. α-Ketoglutaramate, a neurotoxic agent in hepatic coma. Trans Assoc Am Physicians 1973, 86:255-263.
116. Vergara E., Plum F., Duffy T.E. α-Ketoglutaramate: increased concentrations in the cerebrospinal fluid of patients in hepatic coma. Science 1974, 183:81-83.
117. Duffy T.E., Vergara F., Plum F. α-Ketoglutaramate in hepatic encephalopathy. Res Publ Assoc Res Nerv Ment Dis 1974, 53:39-52.
118. Albrecht J., Norenberg M.D. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology 2006, 44:788-794.
119. Murthy C.R.K., Rama Rao K.V., Bai G., Norenberg M.D. Ammonia-induced production of free radicals in primary cultures of rat astrocytes. J Neurosci Res 2001, 66:282-288.
120. Rama Rao K.V., Jayakumar A.R., Norenberg M.D. Ammonia neurotoxicity: role of the mitochondrial permeability transition. Metab Brain Dis 2003, 18:113-127.
121. Jayakumar A.R., Rama Rao K.V., Schousboe A., Norenberg M.D. Glutamine-induced free radical production in cultured astrocytes. Glia 2004, 46:296-301.
122. Jayakumar A.R., Rao K.V., Murthy ChR., Norenberg M.D. Glutamine in the mechanism of ammonia-induced astrocyte swelling. Neurochem Int 2006, 48:623-628.
123. Jayakumar A.R., Rama Rao K.V., Tong X.Y., Norenberg M.D. Calcium in the mechanism of ammonia-induced astrocyte swelling. J Neurochem 2009, 109(suppl 1):252-257.
124. Norenberg M.D., Rao K.V., Jayakumar A.R. Mechanisms of ammonia-induced astrocyte swelling. Met Brain Dis 2005, 20:303-318.
125. Pichilli V.B.R., Rao K.V., Jayakumar A.R., Norenberg M.D. Inhibition of glutamine transport into mitochondria protects astrocytes from ammonia toxicity. Glia 2007, 55:801-809.
126. Kvamme E., Svenneby G., Hertz L., Schousboe A. Properties of phosphate activated glutaminase in astrocytes cultured from mouse brain. Neurochem Res 1982, 7:761-770.
127. Olalla L., Gutiérrez A., Jiménez A.J., et al. Expression of the scaffolding PDZ protein glutaminase-interacting protein in mammalian brain. J Neurosci Res 2008, 86:281-292.
128. Kvamme E., Nissen-Meyer L.S., Roberg B.A., Torgner I.A. Novel form of phosphate activated glutaminase in cultured astrocytes and human neuroblastoma cells, PAG in brain pathology and localization in the mitochondria. Neurochem Res 2008, 33:1341-1345.
129. 15N nuclear magnetic resonance. Biochem J 1995, 305:329-336.
130. Matheson D.F., Van Den Berg C.J. Ammonia and brain glutamine: inhibition of glutamine degradation by ammonia. Biochem Soc Trans 1975, 3:525-528.
131. Wallace D.R., Dawson R. Ammonia regulation of phosphate-activated glutaminase displays regional variation and impairment in the brain of aged rats. Neurochem Res 1992, 17:1113-1122.
132. Warren K.S., Schenker S. Effect of an inhibitor of glutamine synthesis (methionine sulfoximine) on ammonia toxicity and metabolism. J Lab Clin Med 1964, 64:442-449.
133. Kosenko E., Kaminsky Y., Solomadin I., et al. Acute ammonia neurotoxicity in vivo involves increase in cytoplasmic protein P53 without alterations in other markers of apoptosis. J Neurosci Res 2007, 85:2491-2499.
134. Leung A.W.C., Halestrap A.P. Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore. Biochim Biophys Acta 2008, 1777:946-952.
135. Elgudin L., Hall Y., Schubert D. Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report. Int J Psychiatry Med 2003, 22:91-96.
136. Mak C.M., Siu T.S., Lam C.W., et al. Complete recovery from acute encephalopathy of late-onset ornithine transcarbamylase deficiency in a 3-year-old boy. J Inher Metab Dis 2007, 30:981.
137. Mans A.M., Biebuyck J.F., Hawkins R.A. Ammonia selectively stimulates neutral amino acid transport across blood-brain barrier. Am J Physiol 1983, 245:C74-C77.
138. Brusilow S.W. Inborn errors of ureagenesis. Genetic and metabolic disease in pediatrics 1985, 140-165. Butterworths, London. J.K. Lloyd, C.R. Scriver (Eds.).
139. Watson A.J., Chambers T., Karp J.E., Risch V.R., Walker W.G., Brusilow S.W. Transient idiopathic hyperammonaemia in adults. Lancet 1985, 2:1271-1274.
140. Brusilow S.W., Traystman R.J. Hepatic encephalopathy. N Engl J Med 1986, 314:786-787.
141. Schenker S., Brady C.E. Pathogenesis of hepatic encephalopathy. Hepatic encephalopathies 1994, 442-446. Med-Ed Press, Bloomington, IL. H.O. Conn, J. Bircher (Eds.).
142. Hindfelt B. The effect of acute ammonia intoxication upon the brain energy state in rats pretreated with methionine D-L-sulphoximine. Scand J Clin Invest 1973, 31:289-299.
143. Hindfelt B., Plum F. L-methionine-D,L-sulphoximine and acute ammonia toxicity. J Pharm Pharmac 1975, 27:456-458.
144. Takahashi H., Koehler R.C., Brusilow S.W., Traystman R.J. Glutamine synthetase inhibition prevents cerebral oedema during hyperammonemia. Acta Neurochir 1990, 51(suppl):346-347.
145. Takahashi H., Koehler R.C., Brusilow S.W., Traystman R.J. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. Am J Physiol 1991, 261:H825-H829.
146. Sugimoto H., Koehler R.C., Wilson D.A., Brusilow S.W., Traystman R.J. Methionine sulfoximine, a glutamine synthetase inhibitor, attenuates increased extracellular potassium activity during acute hyperammonemia. J Cerebr Blood Flow Metab 1997, 17:44-49.
147. Blei A.T., Olafsson S., Therrien G., Butterworth R.F. Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis. Hepatology 1994, 19:1437-1444.
148. 2 responsivity by glutamine synthesis inhibition in hyperammonemic rats. Circ Res 1992, 71:1220-1230.
149. Hirata T., Koehler R.C., Kawaguchi T., Brusilow S.W., Traystman R.J. Impaired pial arteriolar reactivity to hypercapnia during hyperammonemia depends on glutamine synthesis. Stroke 1996, 27:729-736.
150. Hirata T., Kawaguchi T., Brusilow S.W., Traytsman R.J., Koehler R.C. Preserved hypocapnic pial arteriolar constriction during hyperammonemia by glutamine synthetase inhibition. Am J Physiol 1999, 276:H456-H463.
151. Kawaguchi T., Brusilow S.W., Traystman R.J., Koehler R.C. Glutamine-dependent inhibition of pial arteriolar dilation to acetylcholine with and without hyperammonemia in the rat. Am J Physiol Regul Integr Comp Physiol 2005, 288:R1612-R1619.
152. Tanigami H., Rebel A., Martin L.J., et al. Effect of glutamine synthetase inhibition on astrocyte swelling and altered astroglial protein expression during hyperammonemia in rats. Neuroscience 2005, 131:437-449.
153. Jonung T., Rigotti P., James J.H., Brackett K., Fischer J.E. Effect of hyperammonemia and methionine sulfoximine on the kinetic parameters of blood-brain transport of leucine and phenylalanine. J Neurochem 1985, 45:308-318.
154. Miller J.D. Volume and pressure in the craniospinal axis. Clin Neurosurg 1975, 22:76-105.
155. Mokri B. The Monro-Kellie hypothesis: applications in CSF volume depletion. Neurology 2001, 56:1746-1748.
156. Oberheim N.A., Wang X., Goldman S., Nedergaard M. Astrocytic complexity distinguishes the human brain. Trends Neurosci 2006, 29:547-553.
157. Zwingmann C., Chatauret N., Rose C., Leibfritz D., Butterworth R.F. Selective alterations of brain osmolytes in acute liver failure: protective effect of mild hypothermia. Brain Res 2004, 999:118-123.
158. Maestri N.E., McGowan K.D., Brusilow S.W. Plasma glutamine concentration: a guide in the management of urea cycle disorders. J Pediatr 1992, 121:259-261.
159. Tuchman M., Yudkoff M. Blood levels of ammonia and nitrogen scavenging amino acids in patients with inherited hyperammonemia. Mol Genet Metab 1999, 66:10-15.
160. Tofteng F., Hauerberg J., Hansen B.A., Pedersen C.B., Jørgensen L., Larsen F.S. Persistent arterial hyperammonemia increases the concentration of glutamine and alanine in the brain and correlates with intracranial pressure in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 2006, 26:21-27.
161. Rovira A., Alonso J., Córdoba J. MR imaging findings in hepatic encephalopathy. AJNR Am J Neuroradiol 2008, 29:1612-1621.
162. Lodi R., Tonon C., Stracciari A., et al. Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics. Neurology 2004, 62:762-766.
163. Kale R.A., Gupta R.K., Saraswat V.A., et al. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006, 43:698-706.
164. 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. AJNR Am J Neuroradiol 2006, 27:1019-1026.
165. Behar K.L., Rothman D.L. In vivo nuclear magnetic resonance studies of glutamate-γ-aminobutyric acid-glutamine cycling in rodent and human cortex: the central role of glutamine. J Nut 2001, 131:2498S-2504S.
166. Bröer A., Deitmer J.W., Bröer S. Astroglial glutamine transport by system N is upregulated by glutamate. Glia 2004, 48:298-310.
167. Schneider H.P., Bröer S., Bröer A., Deitmer J.W. Heterologous expression of the glutamine transporter SNAT3 in Xenopus oocytes is associated with four modes of uncoupled transport. J Biol Chem 2007, 282:3788-3798.
168. + binding. J Biol Chem 2009, 284:25823-25831.
169. Kanamori K., Ross B.D. Suppression of glial glutamine release to the extracellular fluid studied in vivo by NMR and microdialysis in hyperammonemic rat brain. J Neurochem 2005, 94:74-85.
170. Pamiljans V., Krishnaswamy P.R., Dumville G., Meister A. Studies on the mechanism of glutamine synthesis; Isolation and properties of the enzyme from sheep brain. Biochemistry 1962, 1:153-158.
171. Häussinger D., Schliess F. Pathogenetic mechanisms of hepatic encephalopathy. Gut 2008, 57:1156-1165.
172. Zwingmann C., Liebfritz D. Ammonia toxicity under hyponatremic conditions in astrocytes: De novo synthesis of amino acids for the osmoregulatory response. Neurochem Int 2005, 47:39-50.
173. Zielińska M., Law R.O., Albrecht J. Excitotoxic mechanism of cell swelling in rat cortical slices treated acutely with ammonia. Neurochem Int 2003, 43:299-303.
174. Sonnewald U., Therrien G., Butterworth R.F. Portacaval anastomosis results in altered neuron-astrocytic metabolic trafficking of amino acids. J Neurochem 1996, 67:1711-1717.
175. Kanamori K., Ross B.D., Chung J.C., Kuo E.L. Severity of hyperammonemic encephalopathy correlates with brain ammonia levels and saturation of glutamine synthetase in vivo. J Neurochem 1996, 67:1584-1594.
176. Dong G., Benveniste E.N. Immune function of astrocytes. Glia 2001, 36:180-190.
177. Stravitz R.T., Kramer A.H., Davern T., et al. ; the Acute Liver Failure Study Group. Crit Care Med 2007, 35:2498-2508.
178. Kimelberg H.K. Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy. Glia 2005, 50:389-397.
179. Kimelberg H.K., Macvicar B.A., Sontheimer H. Anion channels in astrocytes: biophysics, pharmacology, and function. Glia 2006, 54:747-757.
180. Eisenberg D., Gill H.S., Pfluegl G.M.U., Rotstein S.H. Structure-function relationships of glutamine synthetases. Biochim Biophys Acta 2000, 1477:122-145.
181. Laake J.H., Slyngstad T.A., Haug F.M., Ottersen O.P. Glutamine from glial cells is essential for the maintenance of the nerve terminal pool of glutamate: immunogold evidence from hippocampal slice cultures. J Neurochem 1995, 65:871-881.
182. Zielińska M., Stafiej A., Law R.O., Albrecht J. Effects of methionine sulfoximine on the glutamine and glutamate content and cell volume in rat cerebral cortical slices: involvement of mechanisms not related to inhibition of glutamine synthesis. Neurotoxicology 2004, 25:443-449.
183. Tews J.K., Stone W.E. Effects of methionine sulfoximine on levels of free amino acids and related substances in brain. Biochem Pharmacol 1964, 13:543-545.
184. Van den Berg C.J., Van den Velden J. The effect of methionine sulphoximine on the incorporation of labelled glucose, acetate, phenylalanine and proline into glutamate and related amino acids in the brains of mice. J Neurochem 1970, 17:985-991.
185. Gershoff S.N., Elvehjem C.A. The relative effect of methionine sulfoximine on different animal species. J Nutr 1951, 45:451-458.
186. Sellinger O.Z., Azcurra J.M., Ohlsson W.G. Methionine sulfoximine seizures. VIII. The dissociation of the convulsant and glutamine synthetase inhibitory effects. J Pharmacol Exp Ther 1968, 164:212-222.
187. Folbergrová J. Glycogen and glycogen phosphorylase in the cerebral cortex of mice under the influence of methionine sulphoximine. J Neurochem 1973, 20:547-557.
188. Schatz R.A., Sellinger O.Z. Effect of methionine and methionine sulfoximine on rat brain S-adenosyl methionine levels. J Neurochem 1975, 24:63-66.
189. Sellinger O.Z., Schatz R.A., Porta R., Wilens T.E. Brain methylation and epileptogenesis: the case of methionine sulfoximine. Ann Neurol 1984, 16(suppl):S115-S120.
190. Rowe W.B., Meister A. Identification of L-methionine-S-sulfoximine as the convulsant isomer of methionine sulfoximine. Proc Natl Acad Sci USA 1970, 66:500-506.
191. Griffith O.W., Meister A. Differential inhibition of glutamine and γ-glutamylcysteine synthetases by α-alkyl analogs of methionine sulfoximine that induce convulsions. J Biol Chem 1978, 253:2333-2338.
192. Rao S.L.N., Meister A. In vivo formation of methionine sulfoximine phosphate, a protein-bound metabolite of methionine sulfoximine. Biochemistry 1972, 11:1123-1127.
193. Cooper A.J.L., Stephani R.A., Meister A. Enzymatic reactions of methionine sulfoximine. Conversion to the corresponding α-imino and α-keto acids, and to α-ketobutyrate and methane sulfinimide. J Biol Chem 1976, 251:6674-6682.
194. Newell G.W., Erickson T.C., Gilson W.E., Gershoff S.N., Elvehjem C.A. Studies on human subjects receiving highly ageinized food materials. J Lab Clin Med 1949, 34:239-245.
195. Pollack G.H. Species specificity of agene toxicity. J Appl Physiol 1949, 1:802-806.
196. Blin M., Crusio W.E., Hévor T., Cloix J.-F. Chronic inhibition of glutamine synthetase is not associated with impairment of learning and memory in mice. Brain Res Bull 2002, 57:11-15.
197. Eid T., Ghosh A., Wang Y., et al. Recurrent seizures and brain pathology after inhibition of glutamine synthetase in the hippocampus in rats. Brain 2008, 131:2061-2070.